PORT | ENG

About us

Adavium Medical is the largest Brazilian medical equipment and diagnostics company, with Brazil being the third largest private healthcare market in the world. The Company was formed with the intent to bring commercial sophistication to a highly fragmented market, partnering with some of the most innovative companies in the world, and developing and commercializing complementary high-quality, yet cost-effective, products that we develop on our own for the value-based – or “long tail” – segment of the market in Brazil and in other emerging markets.

When many in the medical device and diagnostics industry think about Brazil, what commonly comes to mind is a large vibrant market, but with complex regulatory requirements, loose standards, limited commercial sophistication and a high cost of capital. By navigating this complexity, we have built a commercial leader in Brazil.

Adavium Medical was formed with the intent to commercialize the most innovative portfolio of medical device and diagnostics products in Brazil. Our portfolio today is made up of products that we commercialize on behalf of leading international companies.

We have assembled an experienced team of more than 300 employees that ensure that our fully-integrated commercial platform operates at world-class standards.

We have chosen to specialize in two segments that we can “own”:
• Medical devices, focused on aesthetics, dermatology, plastic surgery, vascular surgery and gynecology
• Clinical diagnostics, focused on equipment and reagents used by clinical laboratories

Both markets are $1 billion markets individually, with substantial growth potential driven by demographics and the growing privatization of healthcare.

We have the largest customer base across premium and “long tail” customers of any medical equipment and/or diagnostics company in Brazil, with more than 2,500 customers respectively in medical equipment and diagnostics. This is exponentially more than the average distributor or multinational in the region.

ABOUTUS_01_C

The Expert in Brazil’s Medical Device and Diagnostics Industry


We understand Brazil from a sophisticated, comprehensive perspective and have very experienced leaders from multinationals in Brazil that understand how to navigate this challenging environment. Our team takes a world-class approach to regulatory, quality, manufacturing, compliance, ethics, customer relationship management and financing, applying discipline to an undisciplined region.

In short, we make the process of commercializing medical technology in Brazil easy for our partners.

We collaborate with ANVISA to ensure fast regulatory approvals, work to ISO manufacturing and distribution standards, are compliant with Department of Justice anti-corruption standards (FCPA) and utilize world-class auditors for the highest levels of financial compliance.

With Brazil’s population of 200 million growing rapidly and with a private healthcare market larger than any other country in the world except the US and China, our partners cannot afford to bypass the region, or to fail.

ABOUTUS_02

A Product Engine for Value Products


In addition to our leading capabilities to commercialize premium products in Brazil, we also offer products that meet the needs of the “long tail” of the market – customers in this segment value high-quality, yet more affordable options, and are typically neglected. Our R&D activities are focused on developing affordable solutions for customers with unmet needs and manufacturing them in our state-of-the-art, ISO-certified facilities. Many of our proprietary products have leading market share positions in Brazil.

ABOUTUS_03

The Future


We intend to continue consolidating our leadership position in the medical equipment and diagnostic sectors by:
• expanding our commercial partnerships with leading international companies
• developing proprietary, complementary products for markets in Brazil and other emerging economies
• opportunistically acquiring medical device and diagnostics businesses to enhance our commercial capabilities and product portfolio

Our ultimate goal is to bring our unique expertise to emerging markets globally.

Leadership

Fred Aslan, MD, – CEO and Founder

Fred Aslan, MD, – CEO and Founder


fred Born and raised in Brazil, Dr. Fred Aslan is the founder of Adavium Medical (previously known as ADVANCE Medical). He is also affiliated with Venrock, a leading Silicon Valley venture capital firm he joined in 2006. While a full-time investor at Venrock prior to founding Adavium, Dr. Aslan was a co-founder and board member of Receptos Pharmaceuticals, a NASDAQ-listed biotech company, which was subsequently acquired by Celgene for more than $8 billion. He also led Venrock’s investment in Zeltiq, a NASDAQ-listed medical device company that was valued at more than $1 billion. Prior to Venrock, he was Director of Business Development and led Investor Relations at CuraGen, a NASDAQ-listed oncology-focused biotech company, and was a strategy consultant with Boston Consulting Group (BCG). He was named the “2014 Business Professional of the Year” by the Brazilian government, recognizing the achievements of Brazilian professionals living outside of Brazil. He is also a board member of Femasys, a US-based women’s health medical device company, and BayBrazil, a Silicon Valley-based not-for-profit organization promoting ties between Silicon Valley and Brazil. Dr. Aslan received a B.S. in Biology from Duke University, an M.D. from Yale and an M.B.A. from Harvard.

Claudia Goulart - COO

Claudia Goulart – COO


claudia Based in Sao Paulo, Claudia Goulart serves as Adavium Medical’s Chief Operating Officer. Previously, she served as the CEO of GE Healthcare for Latin America from 2003 to 2011. Prior to GE Healthcare, she held senior leadership roles in a number of private equity-backed companies, including serving as Chief Financial Officer at IG (Internet Group do Brasil) and Ferrovia Centro Atlantica. Ms. Goulart presently sits on the board of directors of Pixeon and ToLife. She has a Bachelors Degree in Business/ Managerial Economics from the Universidade Federal de Minas Gerais and a Masters in Applied Psychology from CEMPE. Brazil’s leading business publication – Valor Economico – has named her one of its “Top Female Executives 2011.”

Board

Select below a name to see more info.

Fred Aslan, MD, – CEO and Founder

Born and raised in Brazil, Dr. Fred Aslan is the founder of Adavium Medical (previously known as ADVANCE Medical). He is also affiliated with Venrock, a leading Silicon Valley venture capital firm he joined in 2006. While a full-time investor at Venrock prior to founding Adavium, Dr. Aslan was a co-founder and board member of Receptos Pharmaceuticals, a NASDAQ-listed biotech company, which was subsequently acquired by Celgene for more than $8 billion. He also led Venrock’s investment in Zeltiq, a NASDAQ-listed medical device company that was valued at more than $1 billion. Prior to Venrock, he was Director of Business Development and led Investor Relations at CuraGen, a NASDAQ-listed oncology-focused biotech company, and was a strategy consultant with Boston Consulting Group (BCG). He was named the “2014 Business Professional of the Year” by the Brazilian government, recognizing the achievements of Brazilian professionals living outside of Brazil. He is also a board member of Femasys, a US-based women’s health medical device company, and BayBrazil, a Silicon Valley-based not-for-profit organization promoting ties between Silicon Valley and Brazil. Dr. Aslan received a B.S. in Biology from Duke University, an M.D. from Yale and an M.B.A. from Harvard.

Claudia Goulart - COO

Based in Sao Paulo, Claudia Goulart serves as Adavium Medical’s Chief Operating Officer. Previously, she served as the CEO of GE Healthcare for Latin America from 2003 to 2011. Prior to GE Healthcare, she held senior leadership roles in a number of private equity-backed companies, including serving as Chief Financial Officer at IG (Internet Group do Brasil) and Ferrovia Centro Atlantica. Ms. Goulart presently sits on the board of directors of Pixeon and ToLife. She has a Bachelors Degree in Business/ Managerial Economics from the Universidade Federal de Minas Gerais and a Masters in Applied Psychology from CEMPE. Brazil’s leading business publication – Valor Economico – has named her one of its “Top Female Executives 2011.”

Mario Grieco, M.D. - Life Diagnosticos

Mario Grieco, M.D. – Life Diagnosticos


Dr. Grieco is Founder and President of Life Diagnostics. Prior to Life, Dr. Grieco was President of Moksha8, a Latin America-based pharmaceutical company that commercializes therapeutic products in Brazil, Mexico and other Latin American countries. Prior to joining Moksha8, Dr. Grieco was President of Bristol-Myers Squibb (BMS) Brazil, one of the largest pharma companies in Brazil. Prior to BMS, Dr. Grieco was Vice President of Latin America for Pharmacia. Prior to working for Pharmacia, Dr. Grieco held a variety of executive positions at GD Searle where he directed Sales and Marketing efforts for Asia Pacific, Latin America and Canada. Dr. Grieco received his M.D. from the Medical School of Sao Paulo and his M.B.A. from F.S. Camilo in Sao Paulo.

Darren Hite - Aberdare Ventures

Darren Hite – Aberdare Ventures


Mr. Hite is as Partner at Aberdare Ventures, a venture capital firm he joined in 2006. Darren focuses on investments addressing key inefficiencies in large healthcare markets. More recently, Darren has led Aberdare’s investment efforts in healthcare technology companies outside of the US. Darren serves on the board of goBalto, Jiff, and RxAnte, and is the Director of Special Projects at mc10. He was a founding investor in Rock Health and is a mentor for early stage healthcare technology companies through his involvement with Rock Health, Blueprint Health, UCSF, and Stanford. Prior to Aberdare, Darren was a corporate strategy associate at Medtronic and an investment banking analyst at Robertson Stephens. Darren attended the MD program at Georgetown University School of Medicine and the Biodesign program at Stanford University. He holds an A.B. in Evolutionary Biology from Princeton University and an MBA from the Stanford Graduate School of Business.

Paul McCreadie - Arboretum Ventures

Paul McCreadie – Arboretum Ventures


Mr. McCreadie is a Managing Director of Arboretum Ventures, a venture capital firm he joined in 2006. He invests in capital-efficient medical technology, service, and health IT companies focusing on the application of innovative technologies to underserved markets. Paul serves on the board of ArborMetrix, Delphinus Medical Technologies and Wellfount, and is the former Chief Operating Officer for CerviLenz, an Arboretum portfolio company based in Ohio. Prior to joining Arboretum, Mr. McCredie worked at Ford Motor Company for eight years, holding management positions within new product development, manufacturing, and business strategy. He was an associate with the Wolverine Venture Fund (WVF) while an M.B.A. student at Michigan’s Ross School of Business.

Bryan Roberts, Ph.D. - Venrock

Bryan Roberts, Ph.D. – Venrock


Dr. Roberts is a Partner at Venrock, a venture capital firm he joined in 1997. At Venrock, he has invested broadly in healthcare technology including therapeutics, medical devices, and diagnostic companies. Dr. Roberts is Chairman of Ironwood Pharmaceuticals and serves on the board of over a dozen other healthcare technology companies. He has been ranked the #1 healthcare investor by Forbes magazine since 2008 and is a Henry Crown Fellow. Dr. Roberts received a B.A. from Dartmouth College and a Ph.D. in chemistry and chemical biology from Harvard University.

Investors

logo1logo2logo3logo-cliente

This is a unique website which will require a more modern browser to work! Please upgrade today!

TOP